(Q43882760)

English

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Becherer A

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Mitterbauer M

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jaeger U

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kalhs P

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Greinix HT

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Karanikas G

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Pötzi C

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Raderer M

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dudczak R

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kletter K

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

260-267

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402342

0 references

Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Bl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

The performance of a multiwire proportional chamber positron camera for clinical use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402342

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402342

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

release_cypephewobd7hf3shi7yaoha74

1 reference

https://api.fatcat.wiki/v0/release/cypephewobd7hf3shi7yaoha74

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43882760&oldid=2165696698"